Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowNet Cash FlowNet Cash FlowNet IncomeShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

enVVeno Medical (NVNO) Share-based Compensation (2017 - 2020)

enVVeno Medical has reported Share-based Compensation over the past 4 years, most recently at $518186.0 for Q4 2020.

  • For Q4 2020, Share-based Compensation rose 163.45% year-over-year to $518186.0; the TTM value through Dec 2020 reached $881214.0, up 60.88%, while the annual FY2025 figure was $3.4 million, 17.41% down from the prior year.
  • Share-based Compensation for Q4 2020 was $518186.0 at enVVeno Medical, up from $194421.0 in the prior quarter.
  • Over five years, Share-based Compensation peaked at $518186.0 in Q4 2020 and troughed at $37717.0 in Q2 2020.
  • A 4-year average of $183651.7 and a median of $141059.0 in 2018 define the central range for Share-based Compensation.
  • Biggest five-year swings in Share-based Compensation: tumbled 71.15% in 2018 and later soared 163.45% in 2020.
  • Year by year, Share-based Compensation stood at $154296.0 in 2017, then soared by 78.65% to $275648.0 in 2018, then fell by 28.64% to $196695.0 in 2019, then soared by 163.45% to $518186.0 in 2020.
  • Business Quant data shows Share-based Compensation for NVNO at $518186.0 in Q4 2020, $194421.0 in Q3 2020, and $37717.0 in Q2 2020.